GlaxoSmithKline Pharma Q3 net profit declines 61% to Rs 45 crore
GlaxoSmithKline Pharmaceuticals today reported a 61.24 per cent decline in its net profit at Rs 45.30 crore for the October-December period.
By PTI | Updated:
NEW DELHI: GlaxoSmithKline Pharmaceuticals today reported a 61.24 per cent decline in its net profit at Rs 45.30 crore for the October-December period, impacted by supply constraints.
The company had posted a net profit of Rs 116.88 crore during the same period of the previous fiscal.
Net sales rose to Rs 646.15 crore during the quarter under review as against Rs 630.63 crore during the same period of the previous fiscal, GlaxoSmithKline Pharmaceuticals said in a filing to the BSE.
"The quarterly performance was impacted by supply constraints," it added.
GlaxoSmithKline Pharma shares ended at Rs 3,254 a piece on the BSE, down 0.36 per cent from its previous close.
The company had posted a net profit of Rs 116.88 crore during the same period of the previous fiscal.
Net sales rose to Rs 646.15 crore during the quarter under review as against Rs 630.63 crore during the same period of the previous fiscal, GlaxoSmithKline Pharmaceuticals said in a filing to the BSE.
"The quarterly performance was impacted by supply constraints," it added.
GlaxoSmithKline Pharma shares ended at Rs 3,254 a piece on the BSE, down 0.36 per cent from its previous close.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
Related Articles
Accenture logs $18 billion Q3 revenue, revenue misses estimatesADVERTISEMENT
